ConductScience.org, home

Gene · 5300

NIH grants2,100

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitlePIN1 papersNewest fiscal year
ZIAHL001048Nmr Studies Of The Regulation Of Cell Signaling22025
ZIANS003140Regulation of Neuroligins and Effects on Synapse Number and Function22025
F32AI176876Structure-guided design of protease-resistant, lipopeptide inhibitors of SARS-CoV-212025
I01BX000803Ron Receptor Tyrosine Kinase Signaling in Breast Cancer12025
I01BX005791Mixed Lineage Kinase 3 and cytokine signaling axis in hepatocellular carcinoma12025
I01CX002241Mapping DNA Repair and Error-Prone DNA Synthesis in Geriatric Skin12025
IK6BX005690BLRD Research Career Scientist Award Application12025
IK6BX006041BLRD Research Career Scientist Award Application12025
K00DK126120High-throughput dissection of transcriptional regulation in kidney disease12025
K08AA028794Mechanisms of HIF1 alpha mediated dysregulated skeletal muscle proteostasis in alcoholic liver disease12025
K08ES037420Airborne particulates exacerbate vascular remodeling in pulmonary hypertension12025
P01AG026276Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study12025
P01AG047200Comparative genomics of longevity and Alzheimer's disease12025
P01AI143565Biology and structure of pMHC receptors functioning as mechanosensors in the [alpha][beta] T-cell lineage12025
P01CA120964Molecular Pathogenesis of the Hamartoma Syndromes12025
P01HL131477Functional consequences of stem and progenitor cell heterogeneity12025
P01HL136275Immune Cell Interactions in Atherosclerosis12025
P20GM103418Kansas IDeA Network of Biomedical Research Excellence 512025
P20GM103434West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE)12025
P20GM103436IDeA Networks of Biomedical Research Excellence in Kentucky12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/5300/grants?page=4